BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 16613690)

  • 1. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer].
    Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN
    Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer.
    Moriya T; Takiguchi Y; Tabeta H; Watanabe R; Kimura H; Nagao K; Kuriyama T
    Br J Cancer; 2000 Oct; 83(7):858-62. PubMed ID: 10970685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paclitaxel and cisplatin combined with etoposide chemotherapy in non-small cell lung cancer with brain metastases].
    Yang QY; Chen LK; Xu GC; Liu JL; Liang Y; Zhang LN
    Ai Zheng; 2004 Nov; 23(11 Suppl):1459-62. PubMed ID: 15566657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
    Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged oral etoposide therapy in advanced stage lung cancer].
    Bozóky G; Ruby E; Góhér I; Mohos A; Lengyel M
    Orv Hetil; 1997 Jul; 138(28):1791-5. PubMed ID: 9280873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
    Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E
    Lung Cancer; 2007 Jul; 57(1):79-83. PubMed ID: 17383768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
    J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
    Charoentum C; Thongprasert S; Chewasakulyong B
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
    Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC
    Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer.
    Kaira K; Takise A; Kobayashi G; Utsugi M; Horie T; Mori T; Imai H; Inazawa M; Mori M
    Jpn J Clin Oncol; 2005 Feb; 35(2):57-60. PubMed ID: 15709087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly.
    Chen YM; Perng RP; Shih JF; Whang-Peng J
    Lung Cancer; 2008 Aug; 61(2):214-9. PubMed ID: 18243407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of non-small-cell lung cancer by dual (bronchial and pulmonary) arterial drug infusion].
    Shi W; Zhang S; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):146-8. PubMed ID: 7656809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alternating electric heart axis in a patient with small cell lung cancer].
    Hammerschmidt S; Pohlink C; Wirtz H; Rother T
    Dtsch Med Wochenschr; 2004 Jan; 129(1-2):19-22. PubMed ID: 14703576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].
    Fan Y; Huang ZY; Zhang YP; Sun L
    Ai Zheng; 2002 Dec; 21(12):1368-71. PubMed ID: 12520751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
    Cok G; Göksel T; Soyer S; Atil H; Güzelant A; Aysan T
    Tuberk Toraks; 2006; 54(2):161-7. PubMed ID: 16924573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of malignant pericardial effusion due to breast cancer successfully controlled by intrapericardial chemotherapy using pirarubicin].
    Fujito T; Maeura Y; Shimoda M; Hojo S; Yano Y; Matsunaga S
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1757-9. PubMed ID: 11708027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.